Dana Cimilluca of The Wall Street Journal discusses the M&A landscape.
As stock markets surged to record highs this year, investors grew hungrier for opportunities to make deals, pushing M&A activity to pre-recession levels.
David Benoit of The Wall Street Journal discusses activist investor activity in 2014.
S&P Capital IQ Senior Director Rich Peterson, Veracruz Founder Steve Cortes and Morgan Creek Capital Management CEO Mark Yusko discuss how to prepare your portfolio for 2015.
Dana Mattioli of The Wall Street Journal discusses 2014 M&A volume.
Capitalistpig Asset Management’s Jonathan Hoenig and FBN’s Liz MacDonald and Tracy Byrnes on the number of unemployed Americans who do not want to work and the record M&A activity.
Wall Street Journal Reporter David Benoit weighs in on the $66 billion deal for Activis to acquire Allergan .
David Benoit and Liz Hoffman of The Wall Street Journal on activist investor Bill Ackman’s new stake in animal health company Zoetis.
FBN’s Liz MacDonald on Salix shares dropping.
Christopher Davis of Kleinberg Kaplan and David Benoit of The Wall Street Journal discuss Starboards victory in replacing Darden’s board.
David Benoit of The Wall Street Journal breaks down the latest on the fight to take over Allergan .
Wall Street Journal reporters David Benoit and Liz Hoffman on Allergan ’s efforts to buy Salix to ward off Valeant’s hostile bid.
Musician Shooter Jennings sings ‘She Thinks I Still Care’ on Imus.
Fox Business Senior Correspondent Charlie Gasparino on SEC Chair Mary Jo White’s critical comments against Bill Ackman and his Allergan trades.
Pershing Square CEO Bill Ackman discusses his outlook for the probe, why he reinvested in Valiant and how he thinks hedge funds impact the average investor.
Pershing Square founder and CEO Bill Ackman on the 2015 Harbor Investment Conference and why activist investors are important for corporate America.
FBN’s Deidre Bolton talks to Pershing Square Capital Founder and CEO Bill Ackman about the role of the activist investor.
Actavis CEO Brenton Saunders says deal-making strategically supports the company’s goal of dominating the pharma business.
Forbes contributor Rick Ungar, Fort Pitt Capital V.P. Kim Forrest and FBN’s Cheryl Casone on the 2015 outlook for interest rates, the markets and investing like the one percent.
Fox News National Security Analyst KT McFarland and FBN’s Liz MacDonald weigh in on ways to increase U.S. cybersecurity, the best ways to retaliate in a cyber-war and the release of Guantanamo Bay prisoners.